Mettler-Toledo International (NYSE:MTD) Price Target Cut to $1,310.00 by Analysts at Robert W. Baird

Mettler-Toledo International (NYSE:MTDFree Report) had its price target decreased by Robert W. Baird from $1,375.00 to $1,310.00 in a research report report published on Monday,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical instruments supplier’s stock.

Other research analysts have also recently issued reports about the stock. Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Wells Fargo & Company initiated coverage on Mettler-Toledo International in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 price objective for the company. JPMorgan Chase & Co. lifted their target price on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Finally, Stifel Nicolaus lifted their price objective on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a “buy” rating in a report on Monday, August 5th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Mettler-Toledo International has a consensus rating of “Hold” and an average target price of $1,338.75.

Check Out Our Latest Stock Report on Mettler-Toledo International

Mettler-Toledo International Stock Performance

MTD stock opened at $1,250.07 on Monday. The stock’s 50 day simple moving average is $1,398.01 and its 200 day simple moving average is $1,402.52. The company has a market cap of $26.53 billion, a P/E ratio of 33.70, a price-to-earnings-growth ratio of 3.83 and a beta of 1.16. Mettler-Toledo International has a fifty-two week low of $1,015.29 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTDGet Free Report) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 532.25% and a net margin of 21.15%. The company had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Equities analysts predict that Mettler-Toledo International will post 40.34 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other news, insider Christian Magloth sold 1,000 shares of the company’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the transaction, the insider now owns 734 shares of the company’s stock, valued at $1,044,459.98. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.94% of the stock is owned by corporate insiders.

Institutional Trading of Mettler-Toledo International

Hedge funds and other institutional investors have recently modified their holdings of the business. Family Firm Inc. purchased a new position in Mettler-Toledo International in the 2nd quarter valued at approximately $25,000. Blue Trust Inc. grew its position in shares of Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of Mettler-Toledo International during the 3rd quarter valued at $37,000. Rothschild Investment LLC purchased a new stake in Mettler-Toledo International during the 2nd quarter worth about $42,000. Finally, Itau Unibanco Holding S.A. bought a new position in Mettler-Toledo International in the 2nd quarter worth about $42,000. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

(Get Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

See Also

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.